|
132
|
448
|
7uy0A |
Crystal structure of human fgr tyrosine kinase in complex with a-419259 |
|
53
|
132
|
7w8iA |
Crystal structure of zn bound human focal adhesion targeting (fat) domain of the focal adhesion kinase |
|
58
|
145
|
7w7zA |
Crystal structure of human focal adhesion targeting (fat) domain of the focal adhesion kinase |
|
56
|
132
|
7w9uA |
Crystal structure of zn bound human focal adhesion targeting (fat) domain of the focal adhesion kinase |
|
42
|
149
|
7t8jA |
The ubiquitin-associated domain of human thirty-eight negative kinase-1 flexibly fused to the 1tel crystallization chaperone via a gsgg linker |
|
93
|
270
|
8e2mA |
Bruton's tyrosine kinase (btk) with compound 13 |
|
5
|
60
|
7pvzA |
Crystal structure of the intertwined dimer of the c-src sh3 domain e93v-s94a-r95s-t96g mutant |
|
63
|
307
|
8azaA |
Structure of rip2k dimer bound to the xiap bir2 domain |
|
10
|
57
|
7pw2A |
Crystal structure of the abl sh3 domain v73e-a74s-s75r-g76t-d77e mutant |
|
11
|
58
|
7pw0A |
Crystal structure of the c-src sh3 domain n112g-n113y-t114n-e115h mutant |
|
10
|
57
|
7pvvA |
Crystal structure of the abl sh3 domain g92n-y93n-n94t-h95e mutant |
|
12
|
58
|
7pvqA |
Crystal structure of the abl sh3 domain v73e-a74s-s75r-g76t-d77e-g92n-y93n-n94t-h95e mutant in the space group p21221 |
|
11
|
57
|
7pvtA |
Crystal structure of the v-src sh3 domain q128r mutant in complex with the synthetic peptide vsl12 |
|
11
|
56
|
7pvyA |
Crystal structure of the c-src sh3 domain e93v-s94a-r95s-t96g mutant |
|
5
|
59
|
7pvwA |
Crystal structure of the intertwined dimer of the c-src sh3 domain e93v-s94a-r95s-t96g-n112g-n113y-t114n-e115h mutant |
|
11
|
58
|
7pvsA |
Crystal structure of the abl sh3 domain v73e-a74s-s75r-g76t-d77e-g92n-y93n-n94t-h95e mutant in presence of peg 200 |
|
10
|
58
|
7pvrA |
Crystal structure of the abl sh3 domain v73e-a74s-s75r-g76t-d77e-g92n-y93n-n94t-h95e mutant in the space group p41 |
|
13
|
60
|
7pvxA |
Crystal structure of the c-src sh3 domain mutant e93v-s94a-r95s-t96g-n112g-n113y-t114n-e115h in complex with the synthetic peptide vsl12 |
|
86
|
287
|
7uyvA |
Crystal structure of jak3 kinase domain in complex with compound 25 |
|
96
|
288
|
7uyrA |
Crystal structure of tyk2 kinase domain in complex with compound 12 |
|
23
|
106
|
7t1uA |
Crystal structure of a superbinder src sh2 domain (ssrcf) in complex with a high affinity phosphopeptide |
|
82
|
288
|
7uysA |
Crystal structure of tyk2 kinase domain in complex with compound 16 |
|
21
|
99
|
7t1lA |
Crystal structure of a superbinder fes sh2 domain (sfess) in complex with a high affinity phosphopeptide |
|
88
|
290
|
7uywA |
Crystal structure of jak2 kinase domain in complex with compound 30 |
|
84
|
288
|
7uytA |
Crystal structure of tyk2 kinase domain in complex with compound 25 |
|
85
|
289
|
7uyuA |
Crystal structure of tyk2 kinase domain in complex with compound 30 |
|
25
|
102
|
7t1kA |
Crystal structure of a superbinder fes sh2 domain (sfes1) in complex with a high affinity phosphopeptide |
|
93
|
296
|
7rn6A |
High-resolution crystal structure of human jak2 kinase domain (jh1) bound to type-ii inhibitor bbt594 |
|
51
|
254
|
7sa7A |
Crystal structure of the apo sh2 domains of syk |
|
83
|
271
|
7r60A |
Btk in complex with 18a |
|
86
|
270
|
7r61A |
Btk in complex with 25a |
|
91
|
277
|
7ng7A |
Src kinase bound to ecf506 trapped in inactive conformation |
|
90
|
270
|
7n5oA |
Fragment-based discovery of a novel bruton's tyrosine kinase inhibitor |
|
82
|
278
|
7n3uA |
Crystal structure of human wee1 kinase domain in complex with zn-c3 |
|
89
|
270
|
7n5rA |
Fragment-based discovery of a novel bruton's tyrosine kinase inhibitor |
|
90
|
270
|
7n5yA |
Fragment-based drug design of a novel, covalent bruton's tyrosine kinase inhibitor |
|
90
|
270
|
7n5xA |
Fragment-based discovery of a novel bruton's tyrosine kinase inhibitor |
|
84
|
288
|
7k7qA |
Crystal structure of tyrosine kinase 2 jh2 (pseudo kinase domain) complexed with compound-12 aka:6-[(cyclopropanecarbonyl)amino]-4-({3-[6-(dimethylcarbamoyl)pyridazin-3-yl]-2-methoxyphenyl}amino)-n-methylpyridazine-3-carboxamide |
|
80
|
288
|
7k7oA |
Crystal structure of tyrosine kinase 2 jh2 (pseudo kinase domain) complexed with compound-12 aka:6-[(cyclopropanecarbonyl)amino]-4-{[2-methoxy-3-(pyrimidin-2-yl)phenyl]amino}-n-methylpyridazine-3-carboxamide |
|
79
|
276
|
7d57A |
C-src in complex with fiin-2 |
|
88
|
277
|
7ah3A |
Kinase domain of csrc in complex with a pyrazolopyrimidine |
|
15
|
61
|
7a3cA |
Crystal structure of the c-src sh3 domain mutant l100i at ph 3.0 |
|
10
|
61
|
7a2rA |
Crystal structure of the fyn sh3 domain l112v-s114n-s115t-e121l-r123h mutant at ph 6.0 |
|
6
|
57
|
7a3eA |
Intertwined dimer of the c-src sh3 domain mutant t126s |
|
13
|
59
|
7a31A |
Crystal structure of the c-src sh3 domain mutant s94a-t98d-v111l-n113s-t114s at ph 4.5 |
|
14
|
58
|
7a32A |
Crystal structure of the c-src sh3 domain mutant s94a-t98d-v111l-n113s-t114s at ph 7.0 |
|
13
|
59
|
7a33A |
Crystal structure of the c-src sh3 domain mutant s94a-t98d-v111l-n113s-t114s at ph 3.0 |
|
11
|
59
|
7a38A |
Crystal structure of the c-src sh3 domain mutant v111l-n113s-t114s-q128e at ph 6.0 |
|
15
|
60
|
7a37A |
Crystal structure of the c-src sh3 domain mutant v111l-n113s-t114s in 3 m urea |
|
11
|
60
|
7a2oA |
Crystal structure of the fyn sh3 domain l112v-s114n-s115t-e121l-r123h mutant at ph 4.5 |
